ENGORVET

COMPOSITION:

Nandrolone Phenilpropionate ...10mg
Vitamin A.........................47,500 UI
Vitamin D3..........................4750 UI
Vitamin E.............................100 UI
Neutral oil q.s...........................1ml

TARGET SPECIES:

Bovine, sheep and pigs.

DIRECTIONS:

Promotes stimulation in the erythropoiesis and appetite. Promotes growth, development and fattening by a better food/meat conversion. In adult animals or in developing bones and it has a significant rising of the muscle and body mass.

Improve the protein synthesis and mineral’s retention.

DOSE AND ROUTE OF ADMINISTRATION:

Bovines: 1 ml/50 kg.
Ovine: 2 a 5 ml.
Pigs: 2 a 5 ml.

ROUTE OF ADMINISTRATION:

Subcutaneous, only.

WITHRAWAL PERIOD:

30 days.

DESCRIPTION AND PHARMACOLOGICAL CLASS:

Androgenic anabolic steroid found in small quantities naturally in the body of animals. Its positive effects include muscle growth, appetite stimulation and increased red blood cell production.

WARNINGS AND PRECAUTIONS:

A local reaction can occur in the place of the injection in animals to a week of administration.

Avoid excessive use because it can lead to unwanted virilizing effects and aggressive appearance.

STORAGE:

Store in dry and cool places. Protected from direct sunlight.
Store between 0° to 30° C.
KEEP OUT REACH OF CHILDREN AND PETS.

CONTRAINDICATIONS OR RESTRICTIONS:

Do not use in animals with hypersensitivity reactions; if they occur, discontinue treatment.
Do not administer to pregnant animals, animals in poor general condition, in feverish conditions, or in situations of intense stress.
It should not be used repeatedly, or over dose females intended for breeding and/or used as wombs in herds or breeding farms, because it can produce masculinizing effects and increased libido, altering the estrous cycle and ovarian function.
It should not be used in animals with chronic interstitial nephritis.
Very frequent applications in young animals can cause premature ossification and cessation growth.
Do not use in the presence of androgen-dependent tumors, anal adenoma or carcinoma of the prostate and breasts.